For the second year, WMUK has joined a coalition of 20 cancer charities representing rare and less common cancers, in response to the impact caused by COVID-19.
The 20 for 20 campaign is an initiative launched by 20 charities which support people affected by rare and less common cancers.
The campaign launches on 20th September and encourages people to take on a challenge activity for 20 days, based on the number 20. The aim is not only to raise awareness of rare cancers, but to encourage people with symptoms to seek help early, and to empower patients in their treatment journey.
The campaign will help to raise vital funds for charities such as WMUK. Bob, the charity's Patient Support Manager, took a long time being diagnosed, and knows the importance it can have on getting treatment and feeling better.
Bob comments: “Rare cancers like WM don’t get as much exposure as bigger cancers and can be harder to diagnose because many GPs will never have seen a case of it. My advice is to listen to your body and don’t be afraid to ask for further investigation.”
The pandemic has also meant that fundraising has become more difficult. Charities like those behind the 20 for 20 campaign which support patients with rare and less common cancers are also the drivers of key research in these areas but face an uncertain future as income has substantially dropped since the coronavirus pandemic. The aim of the campaign is raise both awareness and money to ensure the charities involved, like WMUK, can continue to help people living with rare and less common cancers.
Get involved and raise funds for WMUK here.
20 for 20 is proudly supported by global biopharmaceutical company Takeda as its headline sponsor.